Off-label use of the Sapien and Sapien XT valves represents a “viable and durable option” for restoring pulmonary valve function in patients with right-ventricular outflow tract (RVOT) disorders, ...

DUBLIN, May 15, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (MDT) today announced results from two late-breaking clinical trials presented virtually at the 2020 Society for Cardiovascular Angiography and ...

For years, innovations in the treatment of pulmonary valve regurgitation have relied on invasive surgical treatments—until now. A device from Medtronic that takes a minimally invasive approach to ...

July 23, 2009 (Gaithersburg, Maryland) — The FDA Circulatory System Devices Panel voted 12 to 0 to recommend approval of a transcatheter pulmonary valve for use under humanitarian device exemption ...

Most patients who undergo percutaneous pulmonary valve implantation for right ventricular outflow tract (RVOT) dysfunction achieve acute hemodynamic benefit within 1 month that is sustained out to at ...

Medtronic delivered new data from two clinical trials evaluating the long-term safety and shorter-term performance of its transcatheter pulmonary valve replacement therapies for children with ...

Ten-year outcomes from the Melody Transcatheter Pulmonary Valve (TPV) Therapy demonstrated strong long-term hemodynamic and safety outcomes, while the first-ever results from the investigational ...